AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Conference Program

Thursday, March 22

Exhibit Hall Hours

11:00 a.m. – 5:00 p.m.

Registration Open

8:30 - 9:20 a.m.

MORNING SYMPOSIUM - Capillary Electrophoresis: A Powerful New Tool for Clinical Labs

9:30 - 11:00 a.m.

Serum Protein Electrophoresis: A Clinical Overview With Case Studies
Samia H. Sobki, MBBS, MSc, FRCPath, Consultant Pathologist, Prince Sultan Military Medical City, Riyadh, Saudi Arabia

Capillary Electrophoresis: A Screening Tool for Haemoglobinopathies
Hisham Shahin, MD, PhD, Assistant Professor of Clinical Pathology, National Cancer Institute, Cairo University and Head of Hematology Unit, Al Borg Medical Laboratories, Jeddah, Saudi Arabia

Panel Discussion 

10:30 - 11:00 a.m.

Coffee Break/Exhibit Hall

11:00 a.m. - 1:00 p.m.

Opening Ceremony

1:00 - 1:30 p.m.

Moderator: Rania Bedair, Head of Molecular Diagnostics and Newborn Screening Units, Al Borg Medical Laboratories, KSA

Welcome and Introductory Remarks
Sameh Elsheikh, MBBS, CEO, Al Borg Medical Laboratories, Jeddah, Saudi Arabia
Janet Kreizman, CEO, AACC, Washington, D.C.

Scientific Conference Information and Overview
David Grenache, PhD, DABCC, Chief Scientific Officer, TriCore Reference Laboratories, Albuquerque, NM

SESSION I - The Importance of Quality Management: Impact on Clinical Decision Making

1:30 – 3:00 p.m. 

Moderator: Nashat Nafouri, Saudi Quality Council (KSA), Chair (Healthcare Interest Group) & Executive Officer 

Ensuring Quality in the Clinical Laboratory: How to Respond When Laboratory Errors Occur
Nikola Baumann, PhD, Co-Director, Central Clinical Laboratory and Central Processing, Mayo Clinic, Rochester, MN

Impact of Quality Systems on Laboratory Performance: Development and Utilization of Quality Indices to Manage Clinical Laboratory Performance
Joe El-Khoury, PhD, DABCC, FAACC, Assistant Professor of Laboratory Medicine and Co-Director, Clinical Chemistry Laboratory, Yale University, New Haven, CT

Panel Discussion

2:30 - 3:00 p.m.

Lunch/Networking/Exhibits

3:10 – 5:10 p.m.


Friday, March 23

Exhibit Hall Hours

10:30 a.m. – 5:30 p.m.

Registration Open

7:30 - 8:45 a.m.

SESSION II: Bridging the Gap Between Lab Medicine and Clinical Decision Making

8:45 – 10:15 a.m.

Moderator: Laila Abdel-Wareth, Chair, Clinical Pathology, Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, UAE

Thyroid Testing in Pregnancy
Ann Gronowski, PhD, DABCC, FAACC, Professor of Pathology and Immunology and Medical Co-Director, Clinical Chemistry, Washington University School of Medicine, St. Louis, MO

Clinical Aspects of Thyroid in Pregnancy
Luca Giovenella, MD, PhD, Head of Nuclear Medicina and PET/CT Centre and Director, EOC Thyroid Diagnosis and Therapy Centre, Oncology Institute of Southern Switzerland, Lugano, Switzerland

Panel Discussion 

9:45 - 10:15 a.m.

Coffee Break

10:15 - 10:30 a.m.

SESSION III: Knowing Your Assay: Is Your Assay Performing to Meet Clinical Needs?

10:30 a.m. – 12:30 p.m.

Moderator: Fayha S. Ahmed, MBBS, MSc (London), FRCPath, CCT, IFCAP, Consultant and Head of Routine Biochemistry Unit Pathology & Genetics Department, Dubai Hospital, UAE 

Interpretation of Lab Results: Treading a Tricky Path
Lamia Mansour, MD, PhD, Professor of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Egypt

Harmonization of the Total Testing Process
Ola Elgaddar, MD, PhD, MBA, Medical Director, Al Borg Medical Laboratories, Abu Dhabi, UAE

A Multicenter Nationwide Reference Intervals Study for Common Biochemical Analytes in Saudi Arabia
Anwar Abdullah Borai, PhD, Assistant Professor, King Saud University for Health Sciences and Research Scientist, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia

Panel Discussion

12:00 - 12:30 p.m.

Lunch/Exhibits/Industry Workshops

12:30 p.m. – 3:00 p.m.

Session IV: Hot Topics in Laboratory Medicine 2018

2:30 – 5:00 p.m.

Moderator: Mahir Al Hilali, Director of Laboratories and Clinical Head of Comprehensive Cancer Centre, Mediclinic Middle East 

Is Laboratory Medicine Ready for Artificial Intelligence?
Baiju Parikh, Global Sales Lead, IBM Watson for Genomics, Cleveland, OH

Digitalization in Laboratory Medicine
Tracy Ellison, PhD, CSci, FIBMS, Head, Clinical Laboratory Pathology and Laboratory Medicine Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

Update on the Diagnosis of Multiple Myeloma
Laila Abdel-Wareth, MBBCh, FRCPC, FCAP, EMHCA, MD, Chair, Clinical Pathology, Pathology & Laboratory Medicine Institute, Cleveland Clinic, Abu Dhabi, UAE

Biotin Interference in Laboratory Testing: Raising Awareness
Nikola Baumann, PhD, Co-Director, Central Clinical Laboratory and Central Processing, Mayo Clinic, Rochester, MN

Panel Discussion

4:30 - 5:00 p.m.

 

Saturday, March 24

Exhibit Hall Hours

10:30 a.m. – 2:30 p.m.

Registration Open

7:00 - 8:00 a.m.

SESSION V: Emerging Diagnostic Technologies: Looking to the Future

8:00 – 10:00 a.m.

Moderator: Brad Davis, Managing Director, Quest Diagnostics, Toronto, Canada

Emerging Technologies and Highlights from AACC’s 2017 Emerging Clinical Laboratory and Diagnostics Conference
Susan Evans, PhD, FAACC, Consultant, BioDecisions Consulting

Next Generation Sequencing: Clinical Laboratory Applications
Andrea Ferreira -Gonzalez, PhD, Professor and Chair of the Division of Molecular Diagnostics, Department of Pathology, Virginia Commonwealth University, Richmond, VA

Mass Spectrometry: What Is Next for Mass Spec?
Joe El-Khoury, PhD, DABCC, FAACC, Assistant Professor of Laboratory Medicine and Co-Director, Clinical Chemistry Laboratory, Yale University, New Haven, CT

Panel Discussion

9:30 - 10:00 a.m.

Coffee Break

10:00 - 10:15 a.m.

SESSION VI: Precision Medicine and Molecular Oncology

10:15 a.m. – 11:45 a.m.

Moderator: Mouza Alsharhan, Head of Pathology, Dubai Hospital, Dubai Health Authority and President of Emirates Medical Association, UAE 

Practical Considerations for Realizing Precision Oncology in Clinical Laboratories
Andrea Ferreira-Gonzalez, PhD, Professor and Chair of the Division of Molecular Diagnostics, Department of Pathology, Virginia Commonwealth University, Richmond, VA

Genetic Risk and Testing for Breast Cancer
Rick Pesano VP, Chief Medical Officer, Global Market and Precision Medicine, Quest Diagnostics, Nichols Institute, San Juan Capistrano, CA

Panel Discussion 

11:15 - 11:45 a.m.

Lunch/Exhibits/Industry Workshops

11:45 - 1:45 p.m.

SESSION VII: Maternal, Fetal, and Newborn: Laboratory, Diagnostics, and Screening

1:45 – 4:15 p.m.

Moderator: Ola Elgaddar, Medical Director, Al Borg Medical Laboratories, UAE 

From Fertility to Delivery: Clinical Laboratory Vignettes
David Grenache, PhD, DABCC, Chief Scientific Officer, TriCore Reference Laboratories, Albuquerque, NM
Ann Gronowski, PhD, DABCC, FAACC, Professor of Pathology and Immunology and Medical Co-Director, Clinical Chemistry, Washington University School of Medicine, St. Louis, MO 
Susan Evans, PhD, FAACC, consultant, BioDecisions Consulting

Newborn Screening Programs: A Road to a Healthy Future
Rania Bedair, MD, PhD, Molecular Diagnostics and Newborn Screening Units Head, Al Borg Medical Laboratories, Jeddah, Saudi Arabia

Panel Discussion

3:45 - 4:15 p.m.

Closing Remarks

4:30 p.m.

Sameh El Sheikh, MBBS, CEO, Al Borg Medical Laboratories, Jeddah, Saudi Arabia
Janet Kreizman, CEO, AACC, Washington, D.C.

Meet the Experts

Learn more about AACC Middle East's distinguished speakers.

View speaker bios

Industry Workshops

In addition to superb science, AACC Middle East will feature workshops presented by diagnostic industry leaders.

Learn more

Conference Venue

Abu Dhabi's Jumeirah at Etihad Towers aim to give guests memorable and enriching experiences.

Learn more